Delivery Order SPE2DE19D0010-SPE2D624F5B8V
- Not listed
- This is a fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Henry Schein, Inc., a large medical and dental supply distributor. The $3,549.44 contract is for the delivery of 4,568,155,725 units of Lidocaine HCL 2% 50S, a local anesthetic, to support the DLA's Medical Supply Chain program. The contract has an ultimate completion date of May 20, 2025 and does not have a set-aside designation, indicating full and open competition. Henry Schein, Inc. holds a larger $234.3...
- This is a $2,563.95 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Henry Schein, Inc., a global medical and dental supply distributor. The order is for 4,566,577,143 units of Lidocaine HCL 2% 50s, a local anesthetic product. The contract has no set-aside designation, indicating it was awarded through full and open competition. Henry Schein holds several significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs and Indian Health...
- This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Henry Schein, Inc., a global distributor of medical and dental supplies. The award, valued at $4,663.85, is for the delivery of lidocaine hydrochloride 2% in 50-count packages. The delivery order is a fixed-price contract with economic price adjustment, with a completion date of November 21, 2024. The contract does not have a set-aside designation, indicating it was competed on a full...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Henry Schein, Inc., a global distributor of medical and dental supplies. The contract is for the provision of 4,565,696 units of Lidocaine HCL 2% 50s, a local anesthetic. The contract has a ceiling value of $3,905.00 and is a fixed-price with economic price adjustment type contract. The period of performance runs through September 19, 2024. This contract does not have a set-aside designation, indicating it was...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Henry Schein, Inc., a global distributor of medical and dental supplies. The contract is for the delivery of 4,564,024,844 units of lidocaine hydrochloride 2% injectable solution, a pharmaceutical product. The contract is a fixed-price with economic price adjustment, has a ceiling value of $1,392.97, and an ultimate completion date of April 2, 2024. The contract does not have a set-aside designation. Henry Schein, Inc....
- This is a delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Henry Schein, Inc. for the delivery of Lidocaine HCL 2% 50 Syringes. The contract is a fixed-price with economic price adjustment and does not have a set-aside designation. The potential value of the contract is $1,551.54 and the completion date is March 7, 2024. Henry Schein, Inc. is a global distributor of medical and dental supplies, and has an extensive history of providing products to...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to Henry Schein, Inc.'s USDG Federal Division on August 21, 2025, for the supply of Lidocaine HCL 2% in 50-unit quantities. The contract, valued at $2,927.20, utilizes a fixed-price structure with economic price adjustment provisions and carries an ultimate completion date of September 5, 2025. This delivery order was issued without a set-aside designation, reflecting full and open competition. The place of performance...
- Henry Schein, Inc.'s USDG Federal Division was awarded a delivery order on September 9, 2025, for the supply of Lidocaine HCL 2% in 50-unit quantities to the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment carries a ceiling value of $3,497.26 and an ultimate completion date of September 23, 2025. The contract utilizes no set-aside designation and represents performance to be fulfilled at the contractor's location in Huntington...
- The U.S. government's Defense Logistics Agency awarded a $1,517.98 fixed-price delivery order contract to Henry Schein, Inc.'s Enterprise Health / Federal Sales Division for the supply of 4564399884 - LIDOCAINE HCL 2% 50S. This contract has an ultimate completion date of May 8, 2024 and was awarded on April 25, 2024. Henry Schein, Inc. is a global distributor of medical and dental supplies that has an extensive history of serving as a prime contractor and subcontractor for numerous federal...
- The Defense Logistics Agency Medical Supply Chain issued a $1,405.79 delivery order to Henry Schein, Inc. on March 2, 2026, for Lidocaine HCL 2% 50s, with an ultimate completion date of March 16, 2026. The order is issued under Henry Schein's $30 million Indefinite Delivery Contract (4610117412) with DLA Troop Support Medical, awarded April 23, 2025, under the Electronic Catalog (ECAT) program. That IDC authorizes procurement of laboratory equipment, supplies, and related items for the...
- SPE2DE19D0010Indefinite Delivery Contract
- SPE2DE19D0010-SPE2D624F5B8VDelivery Order
This is a $1,055.60 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Henry Schein, Inc. for the delivery of lidocaine HCL 2% in 50 count packages. The contract has a period of performance from May 14, 2024 to May 28, 2024 and does not have a set-aside designation, indicating it was competed on a full and open basis. Henry Schein, Inc., a global medical and dental supply distributor, has an extensive history of federal contract awards and subcontracts with agencies such as the Department of Veterans Affairs, Department of Health and Human Services, and Indian Health Service, providing a wide range of healthcare products and services. This specific contract is part of the company's federal supply schedule and will likely support medical operations for the Defense Department or other federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 5/14/24 |